El Hadi H, Di Vincenzo A, Vettor R, Rossato M. Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease. Int j mol ski. 2019; 20 (9): 2215.
Google Scholar
Nedkoff L, Briffa T, Zemedikun D, Herrington S, Wright FL. Global trends in atherosclerotic cardiovascular disease. Clin Ther. 2023;45(11):1087–91.
Google Scholar
Gaziano TA. Cardiovascular diseases worldwide. Public Health Approach Cardiovasc Dis Prev Manag. 2022;1:8–18.
Google Scholar
Rivera J, Loya A, Ceballos R. Use of herbal medicines and implications for conventional drug therapy medical sciences. Altern Integ Med. 2013;2(6):1–6.
Google Scholar
Kavyani Z, Moridpour AH, Falahatzadeh M, Vajdi M, Musazadeh V, Askari G. The effect of berberine supplementation on lipid profile and obesity indices: an umbrella review of meta-analysis. PharmaNutrition. 2023;26:100364.
Google Scholar
Cicero AF, Ertek S. Berberine: metabolic and cardiovascular effects in preclinical and clinical trials. Nutrition and Dietary Supplements. 2009:1–10.
Cicero A, Ertek S. Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results. Clinical Lipidol. 2009;4(5):553–63.
Google Scholar
Safari Z, Farrokhzad A, Ghavami A, Fadel A, Hadi A, Rafiee S, et al. The effect of barberry (Berberis popular L.) on glycemic indices: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;51:102414.
Google Scholar
Firouzi S, Malekahmadi M, Ghayour-Mobarhan M, Ferns G, Rahimi HR. Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action. Diabetes Metabolic Syndrome Obesity Targets Ther. 2018:699–705.
Emamat H, Zahedmehr A, Asadian S, Tangestani H, Nasrollahzadeh J. Effect of barberry (Berberis popular) consumption on blood pressure, plasma lipids, and inflammation in patients with hypertension and other cardiovascular risk factors: study protocol for a randomized clinical trial. Trials. 2020;21(1):986.
Google Scholar
Musazadeh V, Hamidi N, Noormohammadi M, Shidfar F. The Effect of Berber (vulgaris and entitle) on cardiovascular risk factors in patients with type 2 diabetes mellitus: a systematic review, meta-analysis, and GRADE assessment. Curr Ther Res. 2025. https://doi.org/10.1016/j.curtheres.2025.100788.
Google Scholar
Had Arabic A, Ghaed E, Rafiie N, Greeting M. Berberry ABerberis popular L.) is a safe approach for management of lipid parameters: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2019;43:117–24.
Google Scholar
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
Google Scholar
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343.
Granholm A, Alhazzani W, Møller MH. Use of the GRADE approach in systematic reviews and guidelines. Br J Anaesth. 2019;123(5):554–9.
Google Scholar
Andrade C. Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets. J Clin Psychiatry. 2020;81(5):11349.
Google Scholar
Huedo-Medina TB, Sánchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193.
Google Scholar
Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2. Cochrane; 2021. Updated February 2021. Reference Source. 2021.
Montazerifar F, Shoustani S, Hosseini R, Karajibani M, Amanat S, Sedaghat G, et al. Effect of Berberis popular fruit powder on visfatin and metabolic profiles in type 2 diabetes mellitus patients: a randomized, double-blind, placebo-controlled trial. J Herbal Med. 2023;38:100631.
Google Scholar
Emamat H, Asadian S, Zahedmehr A, Ghanavati M, Nasrollahzadeh J. The effect of barberry (Berberis popular) consumption on flow-mediated dilation and inflammatory biomarkers in patients with hypertension: a randomized controlled trial. Phytother Res. 2021;35(5):2607–15.
Google Scholar
Kermani T, Kazemi T, Molki S, Ilkhani K, Sharifzadeh G. The Effect of Berberis vulgaris (Barberry Fruit) on a Component of Metabolic Syndrome: A Randomized Clinical Trial. Modern Care J. 2020;17(2).
Azizi R, Mohammadi A, Khajehlandi A. The effect of aqueous extract of barberry and selected training on some blood factors in men with type2 diabetes (a quasi-experimental study). Jorjani Biomed J. 2020;8(4):11–6.
Google Scholar
Lazavi F, Mirmiran P, Sohrab G, Nikpayam O, Angoorani P, Hedayati M. The barberry juice effects on metabolic factors and oxidative stress in patients with type 2 diabetes: a randomized clinical trial. Complement Ther Clin Pract. 2018;31:170–4.
Google Scholar
Asmani S, Montazeri V, Baradaran B, Tabatabayfar Ma, Pirouzpanah S. The Effects of Berberis popular juice on insulin indices in women with benign breast disease: a randomized controlled clinical trial. Iranian J Pharm Res IJPR. 2018;17(Suppl):110.
Google Scholar
Mansouri A, SadeghSargolzai M, Mir H, Keshavarz N. Investigating the effect of barberry juice consumption on glycated hemoglobin in patients with type II diabetes. Indo Am J Pharm Sci. 2017;4(12):4610–4.
Google Scholar
Zilaee M, Safarian M, Kermany T, Emamian M, Mobarhan M, Ferns G. Effect of barberry treatment on blood pressure in patients with metabolic syndrome. 2015.
Kashkooli RI, Najafi SS, Sharif F, Hamedi A, Asl MKH, Kalyani MN, et al. The effect of Berberis vulgaris extract on transaminase activities in non-alcoholic fatty liver disease. Hepatitis Monthly. 2015;15(2).
Zilaee M, Kermany T, Tavalaee S, Salehi M, Ghayour-Mobarhan M, Ferns GA. Barberry treatment reduces serum anti-heat shock protein 27 and 60 antibody titres and high-sensitivity c-reactive protein in patients with metabolic syndrome: a double-blind, randomized placebo-controlled trial. Phytother Res. 2014;28(8):1211–5.
Google Scholar
Shidfar F, Ebrahimi SS, Hosseini S, Heydari I, Shidfar S, Hajhassani G. The effects of Berberis popular fruit extract on serum lipoproteins, apoB, apoA-I, homocysteine, glycemic control and total antioxidant capacity in type 2 diabetic patients. Iranian J Pharm Res IJPR. 2012;11(2):643.
Google Scholar
ul Hussain H, Ali E, Tanveer A, Ismail SM, Furqan H, Ahsan MN, et al. Efficacy of Berberis popular and Berberis attractives on glycemic indices and weight profile in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. J Ayurveda Integr Med. 2024;15(5):101039.
Google Scholar
Lei L, Li J, Wang B. Efficacy and safety profile of berberine treatment in improving risk factors for cardiovascular disease: a systematic review and meta-analysis of randomized, double-blind trials. Cardiol Discov. 2023;3(02):112–21.
Google Scholar
Dong H, Zhao Y, Zhao L, Lu F. The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials. Planta Med. 2013;79(06):437–46.
Google Scholar
Zamani M, Zarei M, Nikbaf-Shandiz M, Hosseini S, Shiraseb F, Asbaghi O. The effects of berberine supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis. Front Nutr. 2022;9:1013055.
Google Scholar
Tabeshpour J, Imenshahidi M, Hosseinzadeh H. A review of the effects of Berberis popular and its major component, berberine, in metabolic syndrome. Iran J Basic Med Sci. 2017;20(5):557–68.
Google Scholar
Liu D, Zhao H, Zhang Y, Hu J, Xu H. Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. Front Pharmacol. 2025;16:1572197.
Google Scholar
Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess. 2003;7(31):1–94.
Google Scholar
Khan SU, Michos ED. Cardiovascular mortality after intensive LDL-cholesterol lowering: does baseline LDL-cholesterol really matter? Am J Prev Cardiol. 2020;1:100013.
Google Scholar
Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51(3):03000605231164548.
Google Scholar
